HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M P Rivera-Fillat Selected Research

aspartimide

7/2010Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M P Rivera-Fillat Research Topics

Disease

1Neoplasms (Cancer)
07/2010

Drug/Important Bio-Agent (IBA)

1aspartimideIBA
07/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2010
1LigandsIBA
07/2010
1Liposomes (Liposome)IBA
07/2010
1Peptides (Polypeptides)IBA
07/2010
1Thrombospondin 1IBA
07/2010

Therapy/Procedure

1Therapeutics
07/2010